NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

$64.70 + 0.22

stock price, NASDAQ: NUVA

Data as of 08/22/17 4:00 p.m. ET

Data provided by Nasdaq. Minimum 15 minutes delayed.